Dicerna Pharma (DRNA) Tops Q3 EPS by 17c

November 7, 2016 4:38 PM EST
Get Alerts DRNA Hot Sheet
Trade DRNA Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Dicerna Pharma (NASDAQ: DRNA) reported Q3 EPS of ($0.68), $0.17 better than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment